Host genetic factors in susceptibility to HIV-1 infection and progression to AIDS

被引：26

作者：

Chatterjee, Koushik ^{[1
]}

机构：

[1] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa

来源：

JOURNAL OF GENETICS | 2010年 / 89卷 / 01期

关键词：

HIV; AIDS; progression; genetics; polymorphism; TUMOR-NECROSIS-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; ALPHA PROMOTER REGION; T-LYMPHOCYTE EPITOPES; SINGLE AMINO-ACID; DISEASE PROGRESSION; HLA-B; CHEMOKINE RECEPTORS; CCR5; POLYMORPHISM;

D O I：

10.1007/s12041-010-0003-4

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

HIV-1 infection has rapidly spread worldwide and has become the leading cause of mortality in infectious diseases. The duration for development of AIDS (AIDS progression) is highly variable among HIV-1 infected individuals, ranging from 2-3 years to no signs of AIDS development in the entire lifetime. Several factors regulate the rate at which HIV-1 infection progresses to AIDS. Host genetic factors play an important role in the outcome of such complex or multifactor diseases as AIDS and are also known to regulate the rate of disease progression. This review focuses on the major host genes reported to affect the progression to AIDS in HIV-1 infected individuals.

引用

页码：109 / 116

页数：8

共 104 条

[91] HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type I infection [J].

Tang, JM ;

Costello, C ;

Keet, IPM ;

Rivers, C ;

LeBlanc, S ;

Karita, E ;

Allen, S ;

Kaslow, RA .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (04) :317-324

[92]

Tomiyama H, 1997, J IMMUNOL, V158, P5026

[93] Mannose-binding lectin: The pluripotent molecule of the innate immune system [J].

Turner, MW .

IMMUNOLOGY TODAY, 1996, 17 (11) :532-540

[94] Evidence for non-random distribution of Fcγ receptor genotype combinations [J].

van der Pol, WL ;

Jansen, MD ;

Sluiter, WJ ;

van de Sluis, B ;

Leppers-van de Straat, FGJ ;

Kobayashi, T ;

Westendorp, RGJ ;

Huizinga, TWJ ;

van de Winkel, JGJ .

IMMUNOGENETICS, 2003, 55 (04) :240-246

[95] Reduced prevalence of the CCR5 Δ32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex [J].

van Rij, RP ;

Portegies, P ;

Hallaby, T ;

Lange, JMA ;

Visser, J ;

Husman, AMD ;

van't Wout, AB ;

Schuitemaker, H .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03) :854-857

[96]

VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.immunol.10.1.411

[97]

WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338

[98] AN ALLELIC POLYMORPHISM WITHIN THE HUMAN TUMOR-NECROSIS-FACTOR-ALPHA PROMOTER REGION IS STRONGLY ASSOCIATED WITH HLA-A1, HLA-B8, AND HLA-DR3 ALLELES [J].

WILSON, AG ;

DEVRIES, N ;

POCIOT, F ;

DIGIOVINE, FS ;

VANDERPUTTE, LBA ;

DUFF, GW .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :557-560

[99] Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant [J].

Winkler, C ;

Modi, W ;

Smith, MW ;

Nelson, GW ;

Wu, XY ;

Carrington, M ;

Dean, M ;

Honjo, T ;

Tashiro, K ;

Yabe, D ;

Buchbinder, S ;

Vittinghoff, E ;

Goedert, JJ ;

O'Brien, TR ;

Jacobson, LP ;

Detels, R ;

Donfield, S ;

Willoughby, A ;

Gomperts, E ;

Vlahov, D ;

Phair, J ;

O'Brien, SJ .

SCIENCE, 1998, 279 (5349) :389-393

[100] CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro [J].

Wu, LJ ;

Paxton, WA ;

Kassam, N ;

Ruffing, N ;

Rottman, JB ;

Sullivan, N ;

Choe, H ;

Sodroski, J ;

Newman, W ;

Koup, RA ;

Mackay, CR .

JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) :1681-1691

← 2 3 4 5 6 7 8 9 10 11 →